Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamphetamine for obesity
ACTRN12612000831886Phase 2Recruiting
- Sponsor
- Nepean Blue Mountains Local Health District
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dextroamphetamine in obesity, sponsored by Nepean Blue Mountains Local Health District. Primary endpoint: Weight loss from baseline. Started Jun 2012; status: recruiting.
02
Drugs
dextroamphetamine
03
Conditions
obesity
Beyond the preview
Go deeper on ACTRN12612000831886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000831886.